Hanno Svoboda
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling, Autism Spectrum Disorder Research, Dementia and Cognitive Impairment Research
Most-Cited Works
- → Mechanosensing is critical for axon growth in the developing brain(2016)657 cited
- → Trial of Prasinezumab in Early-Stage Parkinson’s Disease(2022)368 cited
- → Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease(2022)104 cited
- → Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease(2024)101 cited
- → A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data(2021)81 cited
- → Histone Deacetylases Control Neurogenesis in Embryonic Brain by Inhibition of BMP2/4 Signaling(2008)72 cited
- → RNA-Binding Protein Hermes/RBPMS Inversely Affects Synapse Density and Axon Arbor Formation in Retinal Ganglion Cells In Vivo(2013)62 cited
- → Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial(2024)32 cited
- → Effects of cyclosporine A and its immunosuppressive or non-immunosuppressive derivatives [D-Ser]8-CsA and Cs9 on mitochondria from different brain regions(2010)18 cited